Back to search
Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA) trials may be worth asking aboutClinical trial pipeline · Data from ClinicalTrials.gov
See which Myelodysplastic Syndrome (MDS) With Refractory Anemia (RA) trials may be worth asking aboutNorth America
Europe
Asia-Pacific
Rest of World
Trials may have sites in multiple countries. Filtering shows any trial with at least one site in the selected country.
Alvocidib, a cyclin-dependent kinase 9 (CDK 9) inhibitor, in time-sequential therapy demonstrated significant clinical activity in secondary AML patients with p…
This study will evaluate the safety and effectiveness of treating patients with severe aplastic anemia (SAA) or myelodysplastic syndrome (MDS) with both periphe…
The purpose of this study is to investigate the effects of iron chelation using deferasirox in low and INT-1 risk (referring to the international prognostic sco…